Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Notice to the media - Government of Canada officials to hold a news conference on coronavirus disease and COVID-19 vaccines in Canada

Canada NewsWire June 11, 2021

Mikart acquires state-of-the-art Korsch XM12 to meet client demands for complex formulation development & production of oral solid dose products

PR Newswire June 11, 2021

Trulieve Expands Patient Access with Latest Tampa Dispensary

Canada NewsWire June 11, 2021

Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer

PR Newswire June 11, 2021

KODOCARE Pharmacy's Chad Kodiak, RPh, PharmD, Receives Champion Of Humanistic Care Recognition At Arnold P. Gold Foundation Annual Gala

PR Newswire June 11, 2021

Health Enterprise Partners Completes Recapitalization of AllyAlign Health

PR Newswire June 11, 2021

Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes

PR Newswire June 11, 2021

USA Swimming Partners with BD to Provide COVID-19 Screening for the Olympic Trials and Other Competitive Swimming Events

PR Newswire June 11, 2021

Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou

PR Newswire June 11, 2021

Excelera Network Welcomes BJC HealthCare

PR Newswire June 11, 2021

SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the Treatment of Cystic Fibrosis, at the European Cystic Fibrosis Conference

PR Newswire June 11, 2021

Ryvu Therapeutics Presents Positive Phase I Data for RVU120 at the Virtual 26th Annual Congress of the European Hematology Association. Phase I/II Data for SEL24 (MEN1703) presented by development partner Menarini

PR Newswire June 11, 2021

Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In Relapsed Aml Patients At Eha Virtual Meeting

PR Newswire June 11, 2021

OxThera reports results from Phase 3 ePHex study with Oxabact in primary hyperoxaluria patients with maintained kidney function

PR Newswire June 11, 2021

Vicore announces FDA acceptance for pivotal phase 3 trial of C21 in COVID-19

PR Newswire June 11, 2021

Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presented by Taiko Pharmaceutical and Kitasato University Inactivates over 99.99% of SARS-CoV-2 (COVID-19 Virus)

PR Newswire June 11, 2021

Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3K? selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress

PR Newswire June 11, 2021

New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment

PR Newswire June 11, 2021

Pre-symptomatic Infants with Spinal Muscular Atrophy Achieved Same Motor Milestones as Healthy Children After Treatment with Evrysdi(TM) in RAINBOWFISH

PR Newswire June 11, 2021

Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting

PR Newswire June 10, 2021